01 / Vendor Profile
CYTOPATH BIOPSY LAB INC Federal Contracts and Awards
UEI KC5VWAGMNLT6 · CAGE 7ASS1
Federal contract activity attributed to this vendor identity across FY 2019–FY 2025. Obligations are FPDS accounting transactions, not company revenue.
02 / Federal Business Size
Federal contract market at a glance
Measured consistently across FY 2019–FY 2025.
Across FY 2019–FY 2025, FPDS records attribute $10.20M in net contract obligations to CYTOPATH BIOPSY LAB INC across 209 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.
03 / Spending Trend
CYTOPATH BIOPSY LAB INC contract spending by year
Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.
Total obligations$1.57M
FY 2025ObligationsHistorical spending range
| Fiscal year | Obligations | Actions | Federal customers | Change |
|---|---|---|---|---|
| FY 2019 | $1.03M | 16 | 3 | — |
| FY 2020 | $912.7K | 21 | 2 | −11.2% |
| FY 2021 | $1.60M | 36 | 2 | +75.7% |
| FY 2022 | $1.49M | 31 | 3 | −7.2% |
| FY 2023 | $1.71M | 33 | 2 | +14.6% |
| FY 2024 | $1.90M | 40 | 2 | +11.3% |
| FY 2025 | $1.57M | 32 | 1 | −17.2% |
04 / Federal Customers
Which federal agencies buy from CYTOPATH BIOPSY LAB INC?
Ranked by net obligations during FY 2019–FY 2025.
| Agency | Code | Obligations | Actions | Vendor share |
|---|---|---|---|---|
| 3600 | $9.02M | 191 | 88.4% | |
| 97DH | $1.02M | 12 | 10.0% | |
| 1700 | $87.9K | 1 | 0.9% | |
| 7529 | $80.0K | 5 | 0.8% |
05 / Contracting Offices
Which contracting offices buy from CYTOPATH BIOPSY LAB INC?
Ranked by net obligations during FY 2019–FY 2025.
| Office | Code | Agency | Obligations | Actions | Vendor share |
|---|---|---|---|---|---|
| 36C262 | VETERANS AFFAIRS, DEPARTMENT OF | $2.43M | 18 | 23.8% | |
| 36C241 | VETERANS AFFAIRS, DEPARTMENT OF | $2.12M | 20 | 20.8% | |
| HT0014 | DEFENSE HEALTH AGENCY (DHA) | $1.02M | 12 | 10.0% | |
| 36C242 | VETERANS AFFAIRS, DEPARTMENT OF | $853.2K | 24 | 8.4% | |
| 36C248 | VETERANS AFFAIRS, DEPARTMENT OF | $850.0K | 11 | 8.3% | |
| 36C246 | VETERANS AFFAIRS, DEPARTMENT OF | $780.0K | 41 | 7.6% | |
| 36C259 | VETERANS AFFAIRS, DEPARTMENT OF | $667.0K | 16 | 6.5% | |
| 36C249 | VETERANS AFFAIRS, DEPARTMENT OF | $484.3K | 15 | 4.7% | |
| 36C261 | VETERANS AFFAIRS, DEPARTMENT OF | $391.4K | 8 | 3.8% | |
| 36C247 | VETERANS AFFAIRS, DEPARTMENT OF | $212.5K | 2 | 2.1% |
06 / Top NAICS Industries
Which industries define this vendor’s federal work?
07 / Top Product and Service Codes
What products and services does the government buy from this vendor?
| PSC | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| Q301 | MEDICAL- LABORATORY TESTING | $6.80M | 155 | 4 | 66.6% |
| 6640 | LABORATORY EQUIPMENT AND SUPPLIES | $1.95M | 25 | 2 | 19.1% |
| 6630 | CHEMICAL ANALYSIS INSTRUMENTS | $436.7K | 20 | 1 | 4.3% |
| 6515 | MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $411.6K | 5 | 1 | 4.0% |
| 6550 | IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $395.0K | 2 | 1 | 3.9% |
| 6632 | ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE | $221.4K | 2 | 1 | 2.2% |
08 / Competition Pattern
How was CYTOPATH BIOPSY LAB INC’s federal work competed?
Competition categories describe the procurement path recorded on the underlying contract actions.
09 / Recent Contract Awards
What contract actions were recorded most recently for CYTOPATH BIOPSY LAB INC?
The latest recorded PIIDs connect this profile to the underlying federal award search.
| Award / PIID | Signed | Obligation | Agency / office | NAICS | PSC |
|---|---|---|---|---|---|
| 36C24825N0352 | Sep 11, 2025 | $120.0K | VETERANS AFFAIRS, DEPARTMENT OF 248-NETWORK CONTRACT OFFICE 8 (36C248) | 621511 | 6640 |
10 / Interpreting the Profile
How should you evaluate CYTOPATH BIOPSY LAB INC as a federal contractor?
Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.
Separate obligations from revenue
FPDS obligations are government accounting actions and may include later deobligations.
Follow customer concentration
Agency and office concentration reveals where the vendor’s federal relationships are strongest.
Test market overlap
NAICS and PSC shares show whether the vendor competes in the same markets as your company.
Inspect the awards
Open the PIIDs to verify dates, offices, classifications, and transaction history.